Femara vs aromasin steroids

Additional adverse reactions of any cause observed in the overall clinical trials program (N = 1058) in 5% or greater of patients treated with exemestane 25 mg once daily but not in the comparative study included pain at tumor sites (8%), asthenia (6%), and fever (5%). Adverse reactions of any cause reported in 2% to 5% of all patients treated with exemestane 25 mg in the overall clinical trials program but not in the comparative study included chest pain, hypoesthesia, confusion, dyspepsia , arthralgia, back pain, skeletal pain, infection, upper respiratory tract infection, pharyngitis , rhinitis , and alopecia.

Femara vs aromasin steroids

femara vs aromasin steroids

Media:

femara vs aromasin steroidsfemara vs aromasin steroidsfemara vs aromasin steroidsfemara vs aromasin steroidsfemara vs aromasin steroids